Related Experiment Video
Updated: Jun 27, 2026

09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Red Blood Cell-Encapsulated Nanoparticles for Long-Circulating, Improved Specificity Functional MRI.
Elizabeth J Fear1,2,3, Antonella Antonelli1, Pasant Abdalla1
1Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino 61029, Italy.
Chemical & Biomedical Imaging
|June 26, 2026
Summary
Researchers developed a red blood cell (RBC)-based nanocarrier for superparamagnetic iron oxide nanoparticles (SPIONs). This biomimetic approach enhances MRI contrast agent longevity and functional brain imaging capabilities.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Medical Imaging
Background:
- Nanoparticle MRI contrast agents face limitations like rapid clearance and poor biocompatibility.
- Superparamagnetic iron oxide nanoparticles (SPIONs) are promising but require improved delivery systems.
Purpose of the Study:
- To develop a red blood cell (RBC)-based nanocarrier for SPIONs.
- To enhance the circulation time and translational potential of MRI contrast agents.
- To improve functional MRI (fMRI) signal robustness and specificity.
Main Methods:
- Encapsulation of SPIONs within human RBCs via hypotonic dialysis and resealing.
- In vivo rodent studies to evaluate MRI signal characteristics and functional brain mapping.
- Comparison of RBC-encapsulated SPIONs with free SPIONs and conventional BOLD contrast.
Main Results:
- SPION-loaded RBCs provided robust, long-lasting CBV-weighted fMRI signals (>5-fold stronger than BOLD).
- Improved laminar specificity in functional brain mapping, localizing activity to cortical layer IV.
- Achieved >30 min of stable T2* contrast at a quarter iron dose compared to free SPIONs.
Conclusions:
- RBC encapsulation is a versatile, biocompatible platform for extending nanoparticle circulation.
- This strategy enables high-resolution functional imaging with potential applications in neurology, oncology, and theranostics.
- The biomimetic nanocarrier significantly improves MRI contrast agent performance and translational potential.

